in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Materia Secures NIH Funding to Develop Alternative Reagents
5:22 AM MDT | May 1, 2012 | Alex Scott
Materia (Pasadena, CA), a catalyst firm with an exclusive license for Grubbs catalyst technology, has received a Phase II Fast Track Small Business Technology Transfer grant from the National Institutes of Health (NIH) for the continued development of functional polymers for use in organic synthesis in pharmaceutical applications. The money will go toward the development of Materia’s methesis catalyst system applied to the development and scale-up of reagents for use in drug discovery. The technology has the potential for providing a series of...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee